Trade Mark Journal No.2026/007 13 February 2026

UK00004332806 30 January 2026 (5)

OMVYZE

Class 5
Pharmaceutical and medicinal preparations and substances; vaccines.

Glaxo Group Limited

Representative: Legal Brand Protection, GSK